Congenital Myasthenic Syndrome Clinical Trials in Marseille
2 recruitingMarseille, France
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
Congenital Myasthenic SyndromeCMS
argenx16 enrolled9 locationsNCT06436742
Recruiting
A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4
Congenital Myasthenic Syndrome
argenx100 enrolled20 locationsNCT06078553